ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Corporate Update Webcast
|
|
Stingyass
|
49 |
13K |
0 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
49
|
13K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
One big wrap up
|
|
Stingyass
|
5 |
3.3K |
15 |
24/12/20 |
24/12/20 |
ASX - By Stock
|
5
|
3.3K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Guess the reason for MSB Trading Halt
|
|
Stingyass
|
317 |
157K |
0 |
18/12/20 |
18/12/20 |
ASX - By Stock
|
317
|
157K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Guess the reason for MSB Trading Halt
|
|
Stingyass
|
317 |
157K |
32 |
16/12/20 |
16/12/20 |
ASX - By Stock
|
317
|
157K
|
32
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading halt
|
|
Stingyass
|
796 |
395K |
0 |
16/12/20 |
16/12/20 |
ASX - By Stock
|
796
|
395K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Heart Failure Results
|
|
Stingyass
|
1.0K |
418K |
8 |
15/12/20 |
15/12/20 |
ASX - By Stock
|
1.0K
|
418K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Heart Failure Results
|
|
Stingyass
|
1.0K |
418K |
66 |
15/12/20 |
15/12/20 |
ASX - By Stock
|
1.0K
|
418K
|
66
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Heart Failure Results
|
|
Stingyass
|
1.0K |
418K |
13 |
15/12/20 |
15/12/20 |
ASX - By Stock
|
1.0K
|
418K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Corporate Update Webcast
|
|
Stingyass
|
125 |
55K |
6 |
15/12/20 |
15/12/20 |
ASX - By Stock
|
125
|
55K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Guess the opening price - if ARDS halted due supreme efficacy
|
|
Stingyass
|
416 |
132K |
1 |
14/12/20 |
14/12/20 |
ASX - By Stock
|
416
|
132K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
Stingyass
|
13K |
5.0M |
3 |
03/12/20 |
03/12/20 |
ASX - By Stock
|
13K
|
5.0M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
When, where and how?
|
|
Stingyass
|
13 |
5.9K |
7 |
03/12/20 |
03/12/20 |
ASX - By Stock
|
13
|
5.9K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
Stingyass
|
13K |
5.0M |
3 |
26/11/20 |
26/11/20 |
ASX - By Stock
|
13K
|
5.0M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
Stingyass
|
13K |
5.0M |
5 |
24/11/20 |
24/11/20 |
ASX - By Stock
|
13K
|
5.0M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
TYPE A OUTCOME AND NOVARTIS PARTNERSHIP
|
|
Stingyass
|
111 |
55K |
5 |
22/11/20 |
22/11/20 |
ASX - By Stock
|
111
|
55K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
Stingyass
|
13K |
5.0M |
6 |
21/11/20 |
21/11/20 |
ASX - By Stock
|
13K
|
5.0M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
Stingyass
|
13K |
5.0M |
10 |
20/11/20 |
20/11/20 |
ASX - By Stock
|
13K
|
5.0M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
Stingyass
|
13K |
5.0M |
10 |
20/11/20 |
20/11/20 |
ASX - By Stock
|
13K
|
5.0M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Pfizer announcement
|
|
Stingyass
|
127 |
41K |
5 |
10/11/20 |
10/11/20 |
ASX - By Stock
|
127
|
41K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Stingyass
|
555 |
268K |
2 |
07/10/20 |
07/10/20 |
ASX - By Stock
|
555
|
268K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
FDA/PDUFA calendar for Biotech
|
|
Stingyass
|
24 |
12K |
2 |
30/09/20 |
30/09/20 |
ASX - By Stock
|
24
|
12K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Pick the Closing Price after FDA approval on that day
|
|
Stingyass
|
449 |
189K |
0 |
28/09/20 |
28/09/20 |
ASX - By Stock
|
449
|
189K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Stingyass
|
17K |
6.7M |
5 |
23/09/20 |
23/09/20 |
ASX - By Stock
|
17K
|
6.7M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Stingyass
|
17K |
6.7M |
8 |
23/09/20 |
23/09/20 |
ASX - By Stock
|
17K
|
6.7M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
Stingyass
|
13K |
5.0M |
10 |
18/09/20 |
18/09/20 |
ASX - By Stock
|
13K
|
5.0M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Wins Fierce Biotech Innovation Award for Remestemcel-L
|
|
Stingyass
|
231 |
103K |
4 |
15/09/20 |
15/09/20 |
ASX - By Stock
|
231
|
103K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L
|
|
Stingyass
|
854 |
431K |
3 |
11/09/20 |
11/09/20 |
ASX - By Stock
|
854
|
431K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
A little clarification please
|
|
Stingyass
|
7 |
2.6K |
2 |
09/09/20 |
09/09/20 |
ASX - By Stock
|
7
|
2.6K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DSMB Recommends Continuation of Phase 3 COVID-19 Trial
|
|
Stingyass
|
299 |
139K |
3 |
04/09/20 |
04/09/20 |
ASX - By Stock
|
299
|
139K
|
3
|
|
ASX - By Stock
|
ZIP |
Re:
ZIP $20 Party - FY 21
|
|
Stingyass
|
436 |
243K |
4 |
27/08/20 |
27/08/20 |
ASX - By Stock
|
436
|
243K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
Stingyass
|
2.0K |
692K |
6 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
2.0K
|
692K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
Stingyass
|
13K |
5.0M |
3 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
13K
|
5.0M
|
3
|
|